Clinical trial
A Phase 2 Study Evaluating INCB099280 in Participants With Advanced Squamous Cell Carcinoma
NCT05888844 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study Evaluating INCB099280 in Participants With Advanced Squamous Cell Carcinoma
- Lead sponsor
- Incyte Corporation
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- October 9, 2023
- Completion date
- September 28, 2026
- Enrollment
- 63 (actual)
- Sites
- 77
Conditions
As the registry lists them; a condition with its own page is linked.